Back
KalVista Pharmaceuticals Quote, Financials, Valuation and Earnings
"This Changes Everything" - Trump Hands Millions Massive IRS Gift
Learn More Here
Sell
48
KALV
KalVista Pharmaceuticals
Last Price:
10.17
Seasonality Move:
3.67%
7 Day Trial
ALL ACCESS PASS
$
7
U.S. Government Report Alert Tuesday
Discover the Secret LoopholeKalVista Pharmaceuticals Price Quote
$10.17
-0.28 (-2.68%)
(Updated: November 14, 2024 at 12:10 PM ET)
KalVista Pharmaceuticals Key Stats
Sell
48
KalVista Pharmaceuticals (KALV)
is a Sell
Day range:
$10.44 - $10.97
52-week range:
$7.39 - $16.88
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
33.42
P/B ratio:
3.04%
Volume:
314K
Avg. volume:
270.4K
1-year change:
35.36%
Market cap:
$525.1M
Revenue:
$0
EPS:
$-3.58
How Much Does KalVista Pharmaceuticals Make?
Data Unavailable
Is KalVista Pharmaceuticals Growing As A Company?
Data Unavailable
KalVista Pharmaceuticals Stock Price Performance
-
Did KalVista Pharmaceuticals Stock Go Up Last Month?
KalVista Pharmaceuticals share price went down by -10.15% last month -
Did KALV's Share Price Rise Over The Last Year?
KALV share price rose by 35.36% over the past 1 year
What Is KalVista Pharmaceuticals 52-Week High & Low?
-
What Is KalVista Pharmaceuticals’s 52-Week High Share Price?
KalVista Pharmaceuticals has traded as high as $16.88 over the past 52 weeks -
What Is KalVista Pharmaceuticals’s 52-Week Low Share Price?
KalVista Pharmaceuticals has traded as low as $7.39 over the past 52 weeks
KalVista Pharmaceuticals Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy KalVista Pharmaceuticals?
-
How Much Debt Does KalVista Pharmaceuticals Have?
Total long term debt quarterly is $0 -
How Much Cash Does KalVista Pharmaceuticals Have?
Cash and short term investments quarterly total is $174.3M -
What Is KalVista Pharmaceuticals’s Book Value Per Share?
Book value per share is 4.01
Is KalVista Pharmaceuticals Cash Flow Positive?
-
What Is KALV Cash Flow From Operations?
Cash flow from operations (TTM) is -$102.7M -
What Is KalVista Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is $153.5M -
What Is KalVista Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$67.2M
KalVista Pharmaceuticals Return On Invested Capital
Data Unavailable
KalVista Pharmaceuticals Earnings Date & Stock Price
-
What Is KalVista Pharmaceuticals's Stock Price Today?
A single share of KALV can be purchased today for 10.45 -
What Is KalVista Pharmaceuticals’s Stock Symbol?
KalVista Pharmaceuticals trades on the nasdaq under the ticker symbol: KALV -
When Is KalVista Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for KalVista Pharmaceuticals is scheduled on December 6, 2024 -
When Is KALV's next ex-dividend date?
KalVista Pharmaceuticals's next ex-dividend date is November 14, 2024 -
How To Buy KalVista Pharmaceuticals Stock?
You can buy KalVista Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
KalVista Pharmaceuticals Competitors
-
Who Are KalVista Pharmaceuticals's Competitors?
Below is a list of companies who compete with KalVista Pharmaceuticals or are related in some way:
KalVista Pharmaceuticals Dividend Yield
-
What Is KALV Dividend Yield?
KalVista Pharmaceuticals’s dividend yield currently is 0% -
What Is KalVista Pharmaceuticals’s Payout Ratio?
KalVista Pharmaceuticals’s payout ratio is 0% -
When Did KalVista Pharmaceuticals Last Pay A Dividend?
The latest dividend pay date is November 14, 2024 -
What Is KalVista Pharmaceuticals’s Dividend Per Share?
KalVista Pharmaceuticals pays a dividend of $0.00 per share
KalVista Pharmaceuticals Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 7.94% |
| Revenue: | 0% | 0% |
Analyst Recommendations
| Buy Recommendations: | 5 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 29.17 |
| Upside from Last Price: | 179.11% |